ArticleAntiviral research2011

Breaking B and T cell tolerance using cationic lipid--DNA complexes (CLDC) as a vaccine adjuvant with hepatitis B virus (HBV) surface antigen in transgenic mice expressing HBV.

John D Morrey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.